Local production of medicines covered 29% of drug sales in Romania in the first six months of 2024, an analysis by market research company Cegedim shows.
Life is Hard (LIH.RO), a technology company listed on the AeRO market of the Bucharest Stock Exchange, posted a consolidated net loss of RON1.7 million in the first half of 2024, from a net profit of RON3.8 million in the year-ago period.